| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.5 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |